Quantcast
 
New book by Larry Connors Click here Improve your trading - See how



Biotech Strength In Weak Market

By Loren Fleckenstein | TradingMarkets.com
Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS

Another bout of selling in tech and financials took down the vast majority of tradable funds Tuesday. The Biotech HOLDR showed strength in an otherwise weak market. Continued anxiety over earnings growth sent money into defensive stocks, lifting pharmaceutical and consumer staples funds.

The Biotech HOLDR (BBH | Quote | Chart | News | PowerRating) gained 2.5%, following through for its third straight gain. It was the sharpest price rise for the day among the exchange-traded funds. Among its components, Human Genome Sciences (HGSI | Quote | Chart | News | PowerRating) rose 6.5%, Genzyme (GENZ | Quote | Chart | News | PowerRating) 3.4%, Alkermes (ALKS | Quote | Chart | News | PowerRating) 5.8%.

Human Genome cleared a 14-week base. Watch out though, those of you who play breakouts for the intermediate-term trade. We're in a bear market until proven otherwise. And breakouts, as Kevin Marder points out in his latest commentary, have a high failure rate in a weak market.

In the defense arena, the Dow Jones U.S. Healthcare iShares (IYH | Quote | Chart | News | PowerRating) added 1.5%, the Utilities SPDR (XLU | Quote | Chart | News | PowerRating) 1.3%, the Consumer Staples SPDR (XLP | Quote | Chart | News | PowerRating) 0.9%, the Pharmaceutical HOLDR (PPH | Quote | Chart | News | PowerRating) 0.8%.

On the downside, the Internet HOLDR (HHH | Quote | Chart | News | PowerRating) tumbled 12.5%, hit by components America Online (AOL | Quote | Chart | News | PowerRating), which dived 17.1%, and Yahoo (YHOO | Quote | Chart | News | PowerRating) down 11.4%.

The Semiconductor HOLDR (SMH | Quote | Chart | News | PowerRating) 5.4%. Among its components, Micron Technology (MU | Quote | Chart | News | PowerRating), the biggest U.S. maker of memory chips, fell 13.9% on downgrades by Morgan Stanley Dean Witter and PaineWebber.

While earnings fears are driving much of the selling, the market has whacked stocks of companies reporting earnings growth rates in excess of analyst expectations. For my technical take on this climate, see my Trading The News.

If you're new to exchange-traded funds, be sure to visit TradingMarkets' Knowledge Center, dedicated to explaining the basics of trading and active investing in ETFs and mutual funds. Just click on the Funds tab near the top of this page, then click on the Knowledge Center tab. 

You also will find lessons on trading exchange-traded funds in the Stocks Education area of TradingMarkets.com. In particular, check out my three-part series on trading ETFs, starting with Moving Average Crossovers. I also recommend newcomers read my tutorial, Trading HOLDRs: Unique Opportunity And Risk.


>> See more articles by Loren Fleckenstein
Stocks RSS
Related Articles
More Related Articles >>
PREMIER SPONSORED LINKS
TRADE CENTER
 
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.